[Federal Register Volume 88, Number 136 (Tuesday, July 18, 2023)]
[Proposed Rules]
[Pages 45824-45825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-15130]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
10 CFR Part 35
[NRC-2022-0218]
RIN 3150-AK91
Reporting Nuclear Medicine Injection Extravasations as Medical
Events
AGENCY: Nuclear Regulatory Commission.
ACTION: Preliminary proposed rule language; extension of comment
period.
-----------------------------------------------------------------------
SUMMARY: On April 19, 2023, the U.S. Nuclear Regulatory Commission
(NRC) solicited feedback on the preliminary proposed rule language and
posed specific questions to stakeholders for a rulemaking on the
reporting of nuclear medicine injection extravasations as medical
events. The public comment period was originally scheduled to close on
July 18, 2023. The NRC has decided to extend the public comment period
to allow more time for members of the public to develop and submit
their comments.
DATES: The due date of comments requested in the document published on
April 19, 2023 (88 FR 24130) is extended. Comments should be filed no
later than September 1, 2023. Comments received after this date will be
considered, if it is practical to do so, but the NRC is able to ensure
consideration only for comments received on or before this date.
ADDRESSES: You may submit comments by any of the following methods;
however, the NRC encourages electronic comment submission through the
Federal rulemaking website:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2022-0218. Address
questions about NRC dockets to Dawn Forder; telephone: 301-415-3407;
email: [email protected]. For technical questions contact the
individuals listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Email comments to: [email protected]. If you do
not receive an automatic email reply confirming receipt, then contact
us at 301-415-1677.
Fax comments to: Secretary, U.S. Nuclear Regulatory
Commission at 301-415-1101.
Mail comments to: Secretary, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001, ATTN: Rulemakings and
Adjudications Staff.
Hand deliver comments to: 11555 Rockville Pike, Rockville,
Maryland 20852, between 7:30 a.m. and 4:15 p.m. eastern time, Federal
workdays; telephone: 301-415-1677.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Irene Wu, Office of Nuclear Material
Safety and Safeguards, telephone: 301-415-1951, email:
[email protected]; and Daniel DiMarco, Office of Nuclear Material Safety
and Safeguards, telephone: 301-415-3303, email: [email protected].
Both are staff of the U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2022-0218 when contacting the NRC
about the availability of information for this action. You may obtain
publicly available information related to this action by any of the
following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2022-0218.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS
Search.'' For problems with ADAMS, please contact the NRC's Public
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737,
or by email to [email protected]. The ADAMS accession number for
each document referenced (if it is available in ADAMS) is provided the
first time that it is mentioned in this document.
NRC's PDR: The PDR, where you may examine and order copies
of publicly available documents, is open by appointment. To make an
appointment to visit the PDR, please send an email to
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8
a.m. and 4 p.m. eastern time, Monday through Friday, except Federal
holidays.
B. Submitting Comments
The NRC encourages electronic comment submission through the
Federal Rulemaking Website (https://www.regulations.gov). Please
include Docket ID NRC-2022-0218 in your comment submission.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC will post all comment submissions at
https://www.regulations.gov as well as enter the comment submissions
into ADAMS. The NRC does not routinely edit comment submissions to
remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Discussion
On April 19, 2023, the NRC solicited feedback on the preliminary
proposed rule language for a rulemaking on the reporting of nuclear
medicine injection extravasations as medical events. To inform this
rulemaking, the NRC also posed specific questions to obtain input from
stakeholders. The public comment period was originally scheduled to
close on July 18, 2023. By email dated July 10, 2023 (ADAMS Accession
No. ML23193A202), the Organization of Agreement States Board requested
that the NRC extend the comment period by 45 days. The NRC has decided
to grant this request and extend the public comment period on this
document until September 1, 2023, to allow more time for members of the
public to submit their comments.
The NRC may post materials related to this document, including
public
[[Page 45825]]
comments, on the Federal rulemaking website at https://www.regulations.gov under Docket ID NRC-2022-0218. In addition, the
Federal rulemaking website allows members of the public to receive
alerts when changes or additions occur in a docket folder. To
subscribe: (1) navigate to the docket folder (NRC-2022-0218); (2) click
the ``Subscribe'' link; and (3) enter an email address and click on the
``Subscribe'' link.
Dated: July 12, 2023.
For the Nuclear Regulatory Commission.
Christopher M. Regan,
Director, Division of Rulemaking, Environmental, and Financial Support,
Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2023-15130 Filed 7-17-23; 8:45 am]
BILLING CODE 7590-01-P